GTHX - G1 Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $19.28. This is a potential upside of $12.13 (169.65%) from yesterday's end of day stock price of $7.15.

G1 Therapeutics's activity chart (see below) currently has 65 price targets and 57 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25.87% with an average time for these price targets to be met of 97.67 days.

Most recent stock forecast was given by GIL BLUM from NEEDHAM on 06-Aug-2024. First documented stock forecast 11-Jun-2017.

Best performing analysts who are covering GTHX - G1 Therapeutics:

Chad Messer David Nierengarten Anupam Rama Dane Leone Gil Blum Edward White

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$6

1 years 2 months 22 days ago
(06-Aug-2024)

1/9 (11.11%)

$3.8 (172.73%)

43

Buy

$3

$-4.15 (-58.04%)

$9

1 years 4 months 4 days ago
(24-Jun-2024)

1/11 (9.09%)

$0.8 (36.36%)

17

Buy

$4

$-3.15 (-44.06%)

$5

1 years 8 months 16 days ago
(12-Feb-2024)

4/8 (50%)

$1.9 (90.48%)

189

Sell

$10

2 years 23 days ago
(05-Oct-2023)

1/5 (20%)

$2.57 (34.59%)

86

Buy

$24

$16.85 (235.66%)

3 years 6 months 3 days ago
(25-Apr-2022)

1/4 (25%)

$18.07 (304.72%)

63

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GTHX (G1 Therapeutics) average time for price targets to be met?

On average it took 97.67 days on average for the stock forecasts to be realized with a an average price target met ratio 25.87

Which analyst has the current highest performing score on GTHX (G1 Therapeutics) with a proven track record?

CHAD MESSER

Which analyst has the current lower performing score on GTHX (G1 Therapeutics) with a proven track record?

EDWARD WHITE

Which analyst has the most public recommendations on GTHX (G1 Therapeutics)?

Chad Messer has 6 price targets and 8 ratings on GTHX

Which analyst is the currently most bullish on GTHX (G1 Therapeutics)?

Chad Messer with highest potential upside - $60.85

Which analyst is the currently most reserved on GTHX (G1 Therapeutics)?

Edward White with lowest potential downside - -$4.15

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?